[{"id":"caa0c76d-9495-4ea2-8043-e5bf0b53ba9a","acronym":"UCPVax-Glio","url":"https://clinicaltrials.gov/study/NCT04280848","created_at":"2021-01-18T20:47:06.612Z","updated_at":"2024-07-02T16:35:29.971Z","phase":"Phase 2","brief_title":"Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma","source_id_and_acronym":"NCT04280848 - UCPVax-Glio","lead_sponsor":"Centre Hospitalier Universitaire de Besancon","biomarkers":" IFNG","pipe":"","alterations":" ","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • UCPVax"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 56","initiation":"Initiation: 05/26/2020","start_date":" 05/26/2020","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2023-11-08"},{"id":"9a62ebc3-ad84-475a-bce4-0564d15944ad","acronym":"UCPVax","url":"https://clinicaltrials.gov/study/NCT02818426","created_at":"2021-01-18T13:48:54.113Z","updated_at":"2024-07-02T16:35:42.954Z","phase":"Phase 1/2","brief_title":"Universal Cancer Peptide-based Vaccination in Metastatic NSCLC","source_id_and_acronym":"NCT02818426 - UCPVax","lead_sponsor":"Centre Hospitalier Universitaire de Besancon","biomarkers":" IFNG","pipe":"","alterations":" ","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e UCPVax"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 04/20/2016","start_date":" 04/20/2016","primary_txt":" Primary completion: 08/30/2022","primary_completion_date":" 08/30/2022","study_txt":" Completion: 12/20/2023","study_completion_date":" 12/20/2023","last_update_posted":"2023-07-14"}]